Novadip and Cliniques universitaires Saint-Luc report positive results for compassionate use of NVD003 on four pediatric patients

NVD003 is a bone grafting material developed to surgically treat patients with Congenital Pseudarthrosis of the Tibia, a rare and difficult-to-treat pediatric disease

Four young patients were treated at Cliniques universitaires Saint-Luc under compassionate use programs managed by Belgian medicines agency, AFMPS

All patients treated with NVD003 had complete healing of their fractures with no recurrent fractures after four to seven years of follow-up

More information on the website of Novadip: https://novadip.com/press-releases/novadip-and-cliniques-universitaires-saint-luc-report-positive-results-for-compassionate-use-of-nvd003-on-four-pediatric-patients/